Alberta Investment Management Corp Seres Therapeutics, Inc. Transaction History

Alberta Investment Management Corp

  • $8.96 Billion
  • Q3 2025

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2019

Aug 14, 2019
SELL
$2.28 - $7.35 $27,815 - $89,670
-12,200 Closed
0 $0
Q1 2019

May 15, 2019
BUY
$4.83 - $7.21 $58,926 - $87,962
12,200 New
12,200 $84,000

Others Institutions Holding MCRB

# of Institutions
4
Shares Held
1.79M
Call Options Held
0
Put Options Held
0
View Full List

About Seres Therapeutics, Inc.

MCRB Quotes by TradingView
  • Ticker MCRB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 124,072,000
  • Market Cap $1.81B
  • Description
  • Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, an oral microbiome therapeutic candidate that has completed Phase III clinical trial for the ...
More about MCRB
Track This Portfolio

Track Alberta Investment Management Corp Portfolio

Follow Alberta Investment Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alberta Investment Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on Alberta Investment Management Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email